Vetera WNV (Canada)This page contains information on Vetera WNV for veterinary use.
The information provided typically includes the following:
- Vetera WNV Indications
- Warnings and cautions for Vetera WNV
- Direction and dosage information for Vetera WNV
Vetera WNVThis treatment applies to the following species:
West Nile Virus Vaccine
Veterinary Use Only
Vetera WNV Indications
For vaccination of healthy horses 4 months of age or older, including pregnant mares, as an aid in the prevention of viremia and mortality, and an aid in the reduction of severity of clinical disease caused by West Nile Virus. The duration of immunity is at least 12 months.
Administration and dosage: Shake well before use. Using aseptic technique, vaccinate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure with a single 1 mL intramuscular dose.
PrecautionsStore at 2-7°C. Protect from freezing. Do not vaccinate within 21 days before slaughter. Use entire contents when first opened. Anaphylactoid reactions may occur following use. Antidote: Epinephrine. Preservatives: Gentamicin and Amphotericin B.
Vetera® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH. Used under license.
Manufactured by: Boehringer Ingelheim Vetmedica, Inc., St. Joseph, Missouri 64506 U.S.A.
US Vet. Lic. No. 124
Manufactured for: Boehringer Ingelheim (Canada) Ltd., Burlington, Ontario L7L 5H4
1 Doses/1 mL
5180 SOUTH SERVICE ROAD, BURLINGTON, ON, L7L 5H4
|Customer Care No.:||1-800-567-1885|
|Technical Services No.:||1-877-565-5501|
|Every effort has been made to ensure the accuracy of the Vetera WNV information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2018 North American Compendiums. Updated: 2018-09-03